ExploreConditionMetabolic Syndrome
Condition

Metabolic Syndrome

Also known as: Cardiovascular Syndrome, Metabolic Cardiovascular Syndromes, Metabolic Dysmetabolic Syndrome X Dysmetabolic syndrome X Insulin Resistance Syndrome X Insulin resistance syndrome Metabolic Cardiovascular Syndrome Metabolic Syndrome Metabolic Syndrome X Metabolic Syndromes Metabolic X Syndrome Metabolic syndrome +14 more
6 findings 1 paper 6 related entities View in graph →

Related entities

interventions
outcomes
populations
studys

Findings (50)

None
mixed

Late preterm (34-<37 weeks) women met Joint Statement MetS criteria (OR 1.82, 95% CI 1.05-2.86), while early preterm (<34 weeks) women had 2-3 times higher risk of hypertriglyceridemia and low HDL but

Effect: mixed; OR 1.82 (late preterm MetS by Joint Statement); CI: 95% CI 1.05, 2.86

Size: OR 1.82 (late preterm MetS by Joint Statement) CI: 95% CI 1.05, 2.86
None
mixed

Late preterm (34-<37 weeks) women met Joint Statement MetS criteria (OR 1.82, 95% CI 1.05-2.86), while early preterm (<34 weeks) women had 2-3 times higher risk of hypertriglyceridemia and low HDL but

Effect: mixed; OR 1.82 (late preterm MetS by Joint Statement); CI: 95% CI 1.05, 2.86

Size: OR 1.82 (late preterm MetS by Joint Statement) CI: 95% CI 1.05, 2.86
None
mixed

Late preterm (34-<37 weeks) women met Joint Statement MetS criteria (OR 1.82, 95% CI 1.05-2.86), while early preterm (<34 weeks) women had 2-3 times higher risk of hypertriglyceridemia and low HDL but

Effect: mixed; OR 1.82 (late preterm MetS by Joint Statement); CI: 95% CI 1.05, 2.86

Size: OR 1.82 (late preterm MetS by Joint Statement) CI: 95% CI 1.05, 2.86
None
mixed

Late preterm (34-<37 weeks) women met Joint Statement MetS criteria (OR 1.82, 95% CI 1.05-2.86), while early preterm (<34 weeks) women had 2-3 times higher risk of hypertriglyceridemia and low HDL but

Effect: mixed; OR 1.82 (late preterm MetS by Joint Statement); CI: 95% CI 1.05, 2.86

Size: OR 1.82 (late preterm MetS by Joint Statement) CI: 95% CI 1.05, 2.86
None
mixed

Late preterm (34-<37 weeks) women met Joint Statement MetS criteria (OR 1.82, 95% CI 1.05-2.86), while early preterm (<34 weeks) women had 2-3 times higher risk of hypertriglyceridemia and low HDL but

Effect: mixed; OR 1.82 (late preterm MetS by Joint Statement); CI: 95% CI 1.05, 2.86

Size: OR 1.82 (late preterm MetS by Joint Statement) CI: 95% CI 1.05, 2.86
None
mixed

Late preterm (34-<37 weeks) women met Joint Statement MetS criteria (OR 1.82, 95% CI 1.05-2.86), while early preterm (<34 weeks) women had 2-3 times higher risk of hypertriglyceridemia and low HDL but

Effect: mixed; OR 1.82 (late preterm MetS by Joint Statement); CI: 95% CI 1.05, 2.86

Size: OR 1.82 (late preterm MetS by Joint Statement) CI: 95% CI 1.05, 2.86
None
mixed

Late preterm (34-<37 weeks) women met Joint Statement MetS criteria (OR 1.82, 95% CI 1.05-2.86), while early preterm (<34 weeks) women had 2-3 times higher risk of hypertriglyceridemia and low HDL but

Effect: mixed; OR 1.82 (late preterm MetS by Joint Statement); CI: 95% CI 1.05, 2.86

Size: OR 1.82 (late preterm MetS by Joint Statement) CI: 95% CI 1.05, 2.86
None
mixed

Late preterm (34-<37 weeks) women met Joint Statement MetS criteria (OR 1.82, 95% CI 1.05-2.86), while early preterm (<34 weeks) women had 2-3 times higher risk of hypertriglyceridemia and low HDL but

Effect: mixed; OR 1.82 (late preterm MetS by Joint Statement); CI: 95% CI 1.05, 2.86

Size: OR 1.82 (late preterm MetS by Joint Statement) CI: 95% CI 1.05, 2.86
None
mixed

Late preterm (34-<37 weeks) women met Joint Statement MetS criteria (OR 1.82, 95% CI 1.05-2.86), while early preterm (<34 weeks) women had 2-3 times higher risk of hypertriglyceridemia and low HDL but

Effect: mixed; OR 1.82 (late preterm MetS by Joint Statement); CI: 95% CI 1.05, 2.86

Size: OR 1.82 (late preterm MetS by Joint Statement) CI: 95% CI 1.05, 2.86
None
mixed

Late preterm (34-<37 weeks) women met Joint Statement MetS criteria (OR 1.82, 95% CI 1.05-2.86), while early preterm (<34 weeks) women had 2-3 times higher risk of hypertriglyceridemia and low HDL but

Effect: mixed; OR 1.82 (late preterm MetS by Joint Statement); CI: 95% CI 1.05, 2.86

Size: OR 1.82 (late preterm MetS by Joint Statement) CI: 95% CI 1.05, 2.86
None
mixed

Late preterm (34-<37 weeks) women met Joint Statement MetS criteria (OR 1.82, 95% CI 1.05-2.86), while early preterm (<34 weeks) women had 2-3 times higher risk of hypertriglyceridemia and low HDL but

Effect: mixed; OR 1.82 (late preterm MetS by Joint Statement); CI: 95% CI 1.05, 2.86

Size: OR 1.82 (late preterm MetS by Joint Statement) CI: 95% CI 1.05, 2.86
None
mixed

Late preterm (34-<37 weeks) women met Joint Statement MetS criteria (OR 1.82, 95% CI 1.05-2.86), while early preterm (<34 weeks) women had 2-3 times higher risk of hypertriglyceridemia and low HDL but

Effect: mixed; OR 1.82 (late preterm MetS by Joint Statement); CI: 95% CI 1.05, 2.86

Size: OR 1.82 (late preterm MetS by Joint Statement) CI: 95% CI 1.05, 2.86
None
mixed

Late preterm (34-<37 weeks) women met Joint Statement MetS criteria (OR 1.82, 95% CI 1.05-2.86), while early preterm (<34 weeks) women had 2-3 times higher risk of hypertriglyceridemia and low HDL but

Effect: mixed; OR 1.82 (late preterm MetS by Joint Statement); CI: 95% CI 1.05, 2.86

Size: OR 1.82 (late preterm MetS by Joint Statement) CI: 95% CI 1.05, 2.86
None
mixed

Late preterm (34-<37 weeks) women met Joint Statement MetS criteria (OR 1.82, 95% CI 1.05-2.86), while early preterm (<34 weeks) women had 2-3 times higher risk of hypertriglyceridemia and low HDL but

Effect: mixed; OR 1.82 (late preterm MetS by Joint Statement); CI: 95% CI 1.05, 2.86

Size: OR 1.82 (late preterm MetS by Joint Statement) CI: 95% CI 1.05, 2.86
None
mixed

Late preterm (34-<37 weeks) women met Joint Statement MetS criteria (OR 1.82, 95% CI 1.05-2.86), while early preterm (<34 weeks) women had 2-3 times higher risk of hypertriglyceridemia and low HDL but

Effect: mixed; OR 1.82 (late preterm MetS by Joint Statement); CI: 95% CI 1.05, 2.86

Size: OR 1.82 (late preterm MetS by Joint Statement) CI: 95% CI 1.05, 2.86
None
mixed

Late preterm (34-<37 weeks) women met Joint Statement MetS criteria (OR 1.82, 95% CI 1.05-2.86), while early preterm (<34 weeks) women had 2-3 times higher risk of hypertriglyceridemia and low HDL but

Effect: mixed; OR 1.82 (late preterm MetS by Joint Statement); CI: 95% CI 1.05, 2.86

Size: OR 1.82 (late preterm MetS by Joint Statement) CI: 95% CI 1.05, 2.86
None
mixed

Late preterm (34-<37 weeks) women met Joint Statement MetS criteria (OR 1.82, 95% CI 1.05-2.86), while early preterm (<34 weeks) women had 2-3 times higher risk of hypertriglyceridemia and low HDL but

Effect: mixed; OR 1.82 (late preterm MetS by Joint Statement); CI: 95% CI 1.05, 2.86

Size: OR 1.82 (late preterm MetS by Joint Statement) CI: 95% CI 1.05, 2.86
None
mixed

Late preterm (34-<37 weeks) women met Joint Statement MetS criteria (OR 1.82, 95% CI 1.05-2.86), while early preterm (<34 weeks) women had 2-3 times higher risk of hypertriglyceridemia and low HDL but

Effect: mixed; OR 1.82 (late preterm MetS by Joint Statement); CI: 95% CI 1.05, 2.86

Size: OR 1.82 (late preterm MetS by Joint Statement) CI: 95% CI 1.05, 2.86
None
mixed

Late preterm (34-<37 weeks) women met Joint Statement MetS criteria (OR 1.82, 95% CI 1.05-2.86), while early preterm (<34 weeks) women had 2-3 times higher risk of hypertriglyceridemia and low HDL but

Effect: mixed; OR 1.82 (late preterm MetS by Joint Statement); CI: 95% CI 1.05, 2.86

Size: OR 1.82 (late preterm MetS by Joint Statement) CI: 95% CI 1.05, 2.86
None
mixed

Late preterm (34-<37 weeks) women met Joint Statement MetS criteria (OR 1.82, 95% CI 1.05-2.86), while early preterm (<34 weeks) women had 2-3 times higher risk of hypertriglyceridemia and low HDL but

Effect: mixed; OR 1.82 (late preterm MetS by Joint Statement); CI: 95% CI 1.05, 2.86

Size: OR 1.82 (late preterm MetS by Joint Statement) CI: 95% CI 1.05, 2.86
None
mixed

Late preterm (34-<37 weeks) women met Joint Statement MetS criteria (OR 1.82, 95% CI 1.05-2.86), while early preterm (<34 weeks) women had 2-3 times higher risk of hypertriglyceridemia and low HDL but

Effect: mixed; OR 1.82 (late preterm MetS by Joint Statement); CI: 95% CI 1.05, 2.86

Size: OR 1.82 (late preterm MetS by Joint Statement) CI: 95% CI 1.05, 2.86
None
mixed

Late preterm (34-<37 weeks) women met Joint Statement MetS criteria (OR 1.82, 95% CI 1.05-2.86), while early preterm (<34 weeks) women had 2-3 times higher risk of hypertriglyceridemia and low HDL but

Effect: mixed; OR 1.82 (late preterm MetS by Joint Statement); CI: 95% CI 1.05, 2.86

Size: OR 1.82 (late preterm MetS by Joint Statement) CI: 95% CI 1.05, 2.86
None
mixed

Late preterm (34-<37 weeks) women met Joint Statement MetS criteria (OR 1.82, 95% CI 1.05-2.86), while early preterm (<34 weeks) women had 2-3 times higher risk of hypertriglyceridemia and low HDL but

Effect: mixed; OR 1.82 (late preterm MetS by Joint Statement); CI: 95% CI 1.05, 2.86

Size: OR 1.82 (late preterm MetS by Joint Statement) CI: 95% CI 1.05, 2.86
None
mixed

Late preterm (34-<37 weeks) women met Joint Statement MetS criteria (OR 1.82, 95% CI 1.05-2.86), while early preterm (<34 weeks) women had 2-3 times higher risk of hypertriglyceridemia and low HDL but

Effect: mixed; OR 1.82 (late preterm MetS by Joint Statement); CI: 95% CI 1.05, 2.86

Size: OR 1.82 (late preterm MetS by Joint Statement) CI: 95% CI 1.05, 2.86
None
mixed

Late preterm (34-<37 weeks) women met Joint Statement MetS criteria (OR 1.82, 95% CI 1.05-2.86), while early preterm (<34 weeks) women had 2-3 times higher risk of hypertriglyceridemia and low HDL but

Effect: mixed; OR 1.82 (late preterm MetS by Joint Statement); CI: 95% CI 1.05, 2.86

Size: OR 1.82 (late preterm MetS by Joint Statement) CI: 95% CI 1.05, 2.86
None
mixed

Late preterm (34-<37 weeks) women met Joint Statement MetS criteria (OR 1.82, 95% CI 1.05-2.86), while early preterm (<34 weeks) women had 2-3 times higher risk of hypertriglyceridemia and low HDL but

Effect: mixed; OR 1.82 (late preterm MetS by Joint Statement); CI: 95% CI 1.05, 2.86

Size: OR 1.82 (late preterm MetS by Joint Statement) CI: 95% CI 1.05, 2.86
None
mixed

Late preterm (34-<37 weeks) women met Joint Statement MetS criteria (OR 1.82, 95% CI 1.05-2.86), while early preterm (<34 weeks) women had 2-3 times higher risk of hypertriglyceridemia and low HDL but

Effect: mixed; OR 1.82 (late preterm MetS by Joint Statement); CI: 95% CI 1.05, 2.86

Size: OR 1.82 (late preterm MetS by Joint Statement) CI: 95% CI 1.05, 2.86
None
decline

Women with prior preterm birth had elevated risk of metabolic syndrome 8 years postpartum compared with women with term births (23% preterm vs 17% control; adjusted OR 1.76, 95% CI 1.06-2.80), driven

Effect: decline; OR 1.76; CI: 95% CI 1.06, 2.80

Size: OR 1.76 CI: 95% CI 1.06, 2.80
None
decline

Women with prior preterm birth had elevated risk of metabolic syndrome 8 years postpartum compared with women with term births (23% preterm vs 17% control; adjusted OR 1.76, 95% CI 1.06-2.80), driven

Effect: decline; OR 1.76; CI: 95% CI 1.06, 2.80

Size: OR 1.76 CI: 95% CI 1.06, 2.80
None
decline

Women with prior preterm birth had elevated risk of metabolic syndrome 8 years postpartum compared with women with term births (23% preterm vs 17% control; adjusted OR 1.76, 95% CI 1.06-2.80), driven

Effect: decline; OR 1.76; CI: 95% CI 1.06, 2.80

Size: OR 1.76 CI: 95% CI 1.06, 2.80
None
decline

Women with prior preterm birth had elevated risk of metabolic syndrome 8 years postpartum compared with women with term births (23% preterm vs 17% control; adjusted OR 1.76, 95% CI 1.06-2.80), driven

Effect: decline; OR 1.76; CI: 95% CI 1.06, 2.80

Size: OR 1.76 CI: 95% CI 1.06, 2.80
None
decline

Women with prior preterm birth had elevated risk of metabolic syndrome 8 years postpartum compared with women with term births (23% preterm vs 17% control; adjusted OR 1.76, 95% CI 1.06-2.80), driven

Effect: decline; OR 1.76; CI: 95% CI 1.06, 2.80

Size: OR 1.76 CI: 95% CI 1.06, 2.80
None
decline

Women with prior preterm birth had elevated risk of metabolic syndrome 8 years postpartum compared with women with term births (23% preterm vs 17% control; adjusted OR 1.76, 95% CI 1.06-2.80), driven

Effect: decline; OR 1.76; CI: 95% CI 1.06, 2.80

Size: OR 1.76 CI: 95% CI 1.06, 2.80
None
decline

Women with prior preterm birth had elevated risk of metabolic syndrome 8 years postpartum compared with women with term births (23% preterm vs 17% control; adjusted OR 1.76, 95% CI 1.06-2.80), driven

Effect: decline; OR 1.76; CI: 95% CI 1.06, 2.80

Size: OR 1.76 CI: 95% CI 1.06, 2.80
None
decline

Women with prior preterm birth had elevated risk of metabolic syndrome 8 years postpartum compared with women with term births (23% preterm vs 17% control; adjusted OR 1.76, 95% CI 1.06-2.80), driven

Effect: decline; OR 1.76; CI: 95% CI 1.06, 2.80

Size: OR 1.76 CI: 95% CI 1.06, 2.80
None
decline

Women with prior preterm birth had elevated risk of metabolic syndrome 8 years postpartum compared with women with term births (23% preterm vs 17% control; adjusted OR 1.76, 95% CI 1.06-2.80), driven

Effect: decline; OR 1.76; CI: 95% CI 1.06, 2.80

Size: OR 1.76 CI: 95% CI 1.06, 2.80
None
decline

Women with prior preterm birth had elevated risk of metabolic syndrome 8 years postpartum compared with women with term births (23% preterm vs 17% control; adjusted OR 1.76, 95% CI 1.06-2.80), driven

Effect: decline; OR 1.76; CI: 95% CI 1.06, 2.80

Size: OR 1.76 CI: 95% CI 1.06, 2.80
None
decline

Women with prior preterm birth had elevated risk of metabolic syndrome 8 years postpartum compared with women with term births (23% preterm vs 17% control; adjusted OR 1.76, 95% CI 1.06-2.80), driven

Effect: decline; OR 1.76; CI: 95% CI 1.06, 2.80

Size: OR 1.76 CI: 95% CI 1.06, 2.80
None
decline

Women with prior preterm birth had elevated risk of metabolic syndrome 8 years postpartum compared with women with term births (23% preterm vs 17% control; adjusted OR 1.76, 95% CI 1.06-2.80), driven

Effect: decline; OR 1.76; CI: 95% CI 1.06, 2.80

Size: OR 1.76 CI: 95% CI 1.06, 2.80
None
decline

Women with prior preterm birth had elevated risk of metabolic syndrome 8 years postpartum compared with women with term births (23% preterm vs 17% control; adjusted OR 1.76, 95% CI 1.06-2.80), driven

Effect: decline; OR 1.76; CI: 95% CI 1.06, 2.80

Size: OR 1.76 CI: 95% CI 1.06, 2.80
None
decline

Women with prior preterm birth had elevated risk of metabolic syndrome 8 years postpartum compared with women with term births (23% preterm vs 17% control; adjusted OR 1.76, 95% CI 1.06-2.80), driven

Effect: decline; OR 1.76; CI: 95% CI 1.06, 2.80

Size: OR 1.76 CI: 95% CI 1.06, 2.80
None
decline

Women with prior preterm birth had elevated risk of metabolic syndrome 8 years postpartum compared with women with term births (23% preterm vs 17% control; adjusted OR 1.76, 95% CI 1.06-2.80), driven

Effect: decline; OR 1.76; CI: 95% CI 1.06, 2.80

Size: OR 1.76 CI: 95% CI 1.06, 2.80
None
decline

Women with prior preterm birth had elevated risk of metabolic syndrome 8 years postpartum compared with women with term births (23% preterm vs 17% control; adjusted OR 1.76, 95% CI 1.06-2.80), driven

Effect: decline; OR 1.76; CI: 95% CI 1.06, 2.80

Size: OR 1.76 CI: 95% CI 1.06, 2.80
None
decline

Women with prior preterm birth had elevated risk of metabolic syndrome 8 years postpartum compared with women with term births (23% preterm vs 17% control; adjusted OR 1.76, 95% CI 1.06-2.80), driven

Effect: decline; OR 1.76; CI: 95% CI 1.06, 2.80

Size: OR 1.76 CI: 95% CI 1.06, 2.80
None
decline

Women with prior preterm birth had elevated risk of metabolic syndrome 8 years postpartum compared with women with term births (23% preterm vs 17% control; adjusted OR 1.76, 95% CI 1.06-2.80), driven

Effect: decline; OR 1.76; CI: 95% CI 1.06, 2.80

Size: OR 1.76 CI: 95% CI 1.06, 2.80
None
decline

Women with prior preterm birth had elevated risk of metabolic syndrome 8 years postpartum compared with women with term births (23% preterm vs 17% control; adjusted OR 1.76, 95% CI 1.06-2.80), driven

Effect: decline; OR 1.76; CI: 95% CI 1.06, 2.80

Size: OR 1.76 CI: 95% CI 1.06, 2.80
None
decline

Women with prior preterm birth had elevated risk of metabolic syndrome 8 years postpartum compared with women with term births (23% preterm vs 17% control; adjusted OR 1.76, 95% CI 1.06-2.80), driven

Effect: decline; OR 1.76; CI: 95% CI 1.06, 2.80

Size: OR 1.76 CI: 95% CI 1.06, 2.80
None
decline

Women with prior preterm birth had elevated risk of metabolic syndrome 8 years postpartum compared with women with term births (23% preterm vs 17% control; adjusted OR 1.76, 95% CI 1.06-2.80), driven

Effect: decline; OR 1.76; CI: 95% CI 1.06, 2.80

Size: OR 1.76 CI: 95% CI 1.06, 2.80
None
decline

Women with prior preterm birth had elevated risk of metabolic syndrome 8 years postpartum compared with women with term births (23% preterm vs 17% control; adjusted OR 1.76, 95% CI 1.06-2.80), driven

Effect: decline; OR 1.76; CI: 95% CI 1.06, 2.80

Size: OR 1.76 CI: 95% CI 1.06, 2.80
None
decline

Women with prior preterm birth had elevated risk of metabolic syndrome 8 years postpartum compared with women with term births (23% preterm vs 17% control; adjusted OR 1.76, 95% CI 1.06-2.80), driven

Effect: decline; OR 1.76; CI: 95% CI 1.06, 2.80

Size: OR 1.76 CI: 95% CI 1.06, 2.80

Papers (1)